Common Bile Duct Diseases: Clinical Trials

5 trials for Common Bile Duct Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Not yet recruiting 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow Common Bile Duct Diseases: new trials by email Literature Review of Common Bile Duct Diseases trials Research Report on Common Bile Duct Diseases

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diclofenac for Prevention of Post-ERC Pancreatitis
Diclofenac - Common Bile Duct Diseases
Phase 2 / Phase 3Not yet recruitingKarolinska Institutet10002026-01-012025-08-13
Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia
4-MUST, Placebo - Chronic Cholecystitis, Biliary Dyskinesia
Phase 3RecruitingValenta Pharm JSC3002025-12-122026-05-19
Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
Endoscopic Retrograde Cholangioscopy by SpyGlass (ERCS) - Common Bile Duct Diseases, Stone - Biliary
Phase 3CompletedChulalongkorn University512015-12-012016-11-18
Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones
ERCP, Endoscopic Sphincterotomy, Large Balloon Dilatation of Oddi Sphincter - Choledocholithiasis, Large Common Bile Duct Stone
Phase 3CompletedSociété Française d'Endoscopie Digestive1502010-07-012015-10-30
Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction)
Duloxetine - Sphincter of Oddi Dysfunction
Phase 3CompletedMedical University of South Carolina182006-07-012014-02-06

Narrower conditions

Biliary Dyskinesia (1)  ·  Cholangitis, Sclerosing (1)  ·  Cholecystolithiasis (1)  ·  Choledocholithiasis (1)  ·  Gallstones (1)  ·  Pancreatitis (1)  ·  Sphincter of Oddi Dysfunction (1)

Broader conditions

Bile Duct Diseases (5)  ·  Biliary Tract Diseases (5)  ·  Digestive System Diseases (5)  ·  Cholelithiasis (2)  ·  Biliary Dyskinesia (1)  ·  Calculi (1)  ·  Cholangitis (1)  ·  Gallbladder Diseases (1)  ·  Pancreatic Diseases (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Cholangiopancreatography, Endoscopic Retrograde (1)  ·  Diclofenac (1)  ·  Duloxetine Hydrochloride (1)  ·  Sphincterotomy, Endoscopic (1)

Sponsors

Chulalongkorn University (1)  ·  Karolinska Institutet (1)  ·  Medical University of South Carolina (1)  ·  Société Française d'Endoscopie Digestive (1)  ·  Valenta Pharm JSC (1)

Countries

Russia (1)  ·  United States (1)

Top investigators

Christopher Lawrence, MD (1)  ·  Gabriel Sandblom, Ass Prof (1)

Results publications

PMID 28753698